Background and aims: The present study aims to asses possible qEEG differences between newly diagnosed Multiple Sclerosis (MS) patients with or without Cognitive Impairment (CI). Methods: We enrolled 13 patiens (18-5 years old) treated with first-line drugs for <6 months, and 16 healthy controls. All subjects underwent neuropsychological assessment including BICAMS and BDI. EEG recordings were performed during a cognitive task (computerised “SDMT” subtest of BICAMS) and at rest (5 minutes before and after task). Based on neuropsychological assessment patients were diagnosed as with -MSCI group- or without -MS group- cognitive impairment: only data from MSCI patients matched for sex, age (±5 years) and education to both an MS patient and a healthy control were analysed. Power spectrum analysis (theta, alpha, beta bands and sub-bands) were performed (EEGlab extension for MatLab). Data were log-transformed and analysed through repeated measures ANOVA. Results: A significant interaction group (MSCI, MS, control) x condition (rest, task) x band (alpha, beta, theta) was observed. Post-hoc analyses showed significant differences between MSCI and both MS and controls in all EEG bands at rest (p<.05), whereas MS patients significantly differed from controls only in alpha2 and beta bands (p<.05). In task condition MSCI significantly differed from controls in alpha and beta bands, whereas MS in theta band (p<.05). Conclusion: If confirmed in larger series, our results seem to support the hypothesis that qEEG differences exist among MSCI, MS and healthy controls, opening to a new possible neurophysiological hallmark of cognitive impairment in MS patients. Disclosure: Nothing to disclose

Nucera, B., Giglia, G., Ragonese, P., Gangitano, M., Luppino, V., Realmuto, S., et al. (2018). Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data. EUROPEAN JOURNAL OF NEUROLOGY, 25, 255-255.

Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data

Nucera, B;Giglia, G;Ragonese, P;Gangitano, M;Realmuto, S;Sardo, P;Salemi, G;Ferraro, G
2018-01-01

Abstract

Background and aims: The present study aims to asses possible qEEG differences between newly diagnosed Multiple Sclerosis (MS) patients with or without Cognitive Impairment (CI). Methods: We enrolled 13 patiens (18-5 years old) treated with first-line drugs for <6 months, and 16 healthy controls. All subjects underwent neuropsychological assessment including BICAMS and BDI. EEG recordings were performed during a cognitive task (computerised “SDMT” subtest of BICAMS) and at rest (5 minutes before and after task). Based on neuropsychological assessment patients were diagnosed as with -MSCI group- or without -MS group- cognitive impairment: only data from MSCI patients matched for sex, age (±5 years) and education to both an MS patient and a healthy control were analysed. Power spectrum analysis (theta, alpha, beta bands and sub-bands) were performed (EEGlab extension for MatLab). Data were log-transformed and analysed through repeated measures ANOVA. Results: A significant interaction group (MSCI, MS, control) x condition (rest, task) x band (alpha, beta, theta) was observed. Post-hoc analyses showed significant differences between MSCI and both MS and controls in all EEG bands at rest (p<.05), whereas MS patients significantly differed from controls only in alpha2 and beta bands (p<.05). In task condition MSCI significantly differed from controls in alpha and beta bands, whereas MS in theta band (p<.05). Conclusion: If confirmed in larger series, our results seem to support the hypothesis that qEEG differences exist among MSCI, MS and healthy controls, opening to a new possible neurophysiological hallmark of cognitive impairment in MS patients. Disclosure: Nothing to disclose
2018
Nucera, B., Giglia, G., Ragonese, P., Gangitano, M., Luppino, V., Realmuto, S., et al. (2018). Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data. EUROPEAN JOURNAL OF NEUROLOGY, 25, 255-255.
File in questo prodotto:
File Dimensione Formato  
RCC_2018_ EAN_ Lisbona_2018.pdf

Solo gestori archvio

Dimensione 509.06 kB
Formato Adobe PDF
509.06 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/308095
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact